Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 14

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Effect of Curcumin on Severity of Functional Dyspepsia: a Triple Blinded Clinical Trial

Panahi, Yunes, Karbasi, Ashraf, Valizadegan, Ghasem, Ostadzadeh, Nayyereh, Soflaei, Sara Saffar, Jamialahmadi, Tannaz, Majeed, Muhammed, Sahebkar, Amirhossein·2021·Advances in Experimental Medicine and Biology
DOI 10.1007/978-3-030-64872-5_10
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-3-030-64872-5_10

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 38

  1. Talley NJ, Ford AC (2015) Functional dyspepsia. N Engl J Med 373(19):1853–1863 · DOI
  2. Imthon AK, Moeller ME, Drewes AM, Juel J, Aziz Q (2015) Functional gastroduodenal disorders. Hamdan Med J 212(2374):1–11
  3. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D (2006) Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 4:CD001960. https://doi.org/10.1002/14651858.CD001960.pub3 · DOI · Paper page
  4. Drossman DA, Dumitrascu DL (2006) Rome III: new standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 15(3):237–241
  5. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M et al (2005) Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 1:CD002096. https://doi.org/10.1002/14651858.CD002096.pub2 · DOI
  6. Van Kerkhoven LA, Laheij RJ, Aparicio N, De Boer WA, Van Den Hazel S, Tan AC et al (2008) Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 6(7):746–752 · DOI
  7. Ly HG, Carbone F, Holvoet L, Bisschops R, Caenepeel P, Arts J et al (2013) 161 mirtazapine improves early satiation, nutrient intake, weight recovery and quality of life in functional dyspepsia with weight loss: a double-blind, randomized, Placebo-Controlled Pilot Study. American Gastroenterological Association | American ...www.gastro.org · DOI
  8. Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW et al (2015) Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology 149(2):340–349.e2 · DOI · Paper page
  9. Tan VP, Cheung TK, Wong WM, Pang R, Wong BC (2012) Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol 18(42):6127–6133 · DOI
  10. Bortolotti M, Coccia G, Grossi G, Miglioli M (2002) The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 16(6):1075–1082 · DOI
  11. Pilichiewicz AN, Horowitz M, Russo A, Maddox AF, Jones KL, Schemann M et al (2007) Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol 102(6):1276–1283 · DOI
  12. Lahner E, Bellentani S, Bastiani RD, Tosetti C, Cicala M, Esposito G et al (2013) A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders. United European Gastroenterol J 1(5):385–393 · DOI
  13. Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M et al (2019) Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr 59(1):89–101 · DOI
  14. Teymouri M, Pirro M, Johnston TP, Sahebkar A (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: a review of chemistry, cellular, molecular, and preclinical features. Biofactors 43(3):331–346 · DOI
  15. Momtazi AA, Derosa G, Maffioli P, Banach M, Sahebkar A (2016) Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases. Mol Diagn Ther 20(4):335–345 · DOI
  16. Ghandadi M, Sahebkar A (2017) Curcumin: An effective inhibitor of interleukin-6. Curr Pharm Des 23(6):921–931 · DOI
  17. Panahi Y, Khalili N, Sahebi E, Namazi S, Simental-Mendía LE, Majeed M, Sahebkar A. Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial. Drug Res (Stuttg). 2018 Jul;68(7):403-409. https://doi.org/10.1055/s-0044-101752. · DOI
  18. Panahi Y, Ahmadi Y, Teymouri M, Johnston TP, Sahebkar A (2018) Curcumin as a potential candidate for treating hyperlipidemia: a review of cellular and metabolic mechanisms. J Cell Physiol 233(1):141−152 · DOI
  19. Panahi Y, Khalili N, Sahebi E, Namazi S, Simental-Mendía LE, Majeed M, et al (2018) Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Res (Stuttg) 68(7):403−409 · DOI
  20. Di Mario F, Cavallaro LG, Nouvenne A, Stefani N, Cavestro GM, Iori V et al (2007) A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter 12(3):238–243 · DOI
  21. Khonche A, Biglarian O, Panahi Y, Valizadegan G, Soflaei S, Ghamarchehreh M et al (2016) Adjunctive therapy with curcumin for peptic ulcer: a randomized controlled trial. Drug Res 66(08):444–448 · DOI · Paper page
  22. Chemnitzer O, Götzel K, Maurer L, Dietrich A, Eichfeld U, Lyros O et al (2017) Response to TNF-α is increasing along with the progression in Barrett’s esophagus. Dig Dis Sci 62(12):3391–3401 · DOI
  23. Czekaj R, Majka J, Ptak-Belowska A, Szlachcic A, Targosz A, Magierowska K et al (2016) Role of curcumin in protection of gastric mucosa against stress-induced gastric mucosal damage. Involvement of hypoacidity, vasoactive mediators and sensory neuropeptides. J Physiol Pharmacol 67(2):261–275
  24. Haider S, Naqvi F, Tabassum S, Saleem S, Batool Z, Sadir S et al (2013) Preventive effects of curcumin against drug-and starvation-induced gastric erosions in rats. Sci Pharm 81(2):549–558 · DOI
  25. He P, Zhou R, Hu G, Liu Z, Jin Y, Yang G et al (2015) Curcumin-induced histone acetylation inhibition improves stress-induced gastric ulcer disease in rats. Mol Med Rep 11(3):1911–1916 · DOI
  26. Kerdsakundee N, Mahattanadul S, Wiwattanapatapee R (2015) Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment. Eur J Pharm Biopharm 94:513–520 · DOI
  27. Liang Z, Wu R, Xie W, Geng H, Zhao L, Xie C et al (2015) Curcumin suppresses MAPK pathways to reverse tobacco smoke-induced gastric epithelial–mesenchymal transition in mice. Phytother Res 29(10):1665–1671 · DOI
  28. Martin RC, Locatelli E, Li Y, Zhang W, Li S, Monaco I et al (2015) Gold nanorods and curcumin-loaded nanomicelles for efficient in vivo photothermal therapy of Barrett’s esophagus. Nanomedicine 10(11):1723–1733 · DOI
  29. Panahi Y, Ghanei M, Hajhashemi A, Sahebkar A (2016) Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: a randomized controlled trial. J Diet Suppl 13(1):93–105 · DOI
  30. Santos A, Lopes T, Oleastro M, Gato I, Floch P, Benejat L et al (2015) Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model. Nutrients 7(1):306–320 · DOI
  31. Panahi Y, Kianpour P, Mohtashami R, Soflaei SS, Sahebkar A (2019) Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study. J Asian Nat Prod Res 21(8):798–805 · DOI
  32. Hu WH, Lam KF, Wong YH, Lam CL, WM HU, Lai KC et al (2002) The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia. J Gastroenterol Hepatol 17(5):545–551
  33. Sarkar A, De R, Mukhopadhyay AK (2016) Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases. World J Gastroenterol 22(9):2736–2748 · DOI
  34. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB et al (2009) Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 53(4):1592–1597 · DOI · Paper page
  35. Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N, Chatsuwan T (2010) Curcumin suppresses gastric NF-kappaB activation and macromolecular leakage in Helicobacter pylori-infected rats. World J Gastroenterol 16(32):4039–4046 · DOI
  36. Foryst-Ludwig A, Neumann M, Schneider-Brachert W, Naumann M (2004) Curcumin blocks NF-κB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun 316(4):1065–1072 · DOI
  37. Kundu P, De R, Pal I, Mukhopadhyay AK, Saha DR, Swarnakar S (2011) Curcumin alleviates matrix metalloproteinase-3 and-9 activities during eradication of Helicobacter pylori infection in cultured cells and mice. PLoS One 6(1):e16306. https://doi.org/10.1371/journal.pone.0016306 · DOI
  38. Vetvicka V, Vetvickova J, Fernandez-Botran R (2016) Effects of curcumin on Helicobacter pylori infection. Ann Transl Med 4(24):479. https://doi.org/10.21037/atm.2016.12.52 · DOI

Cited by

Metadata

Authors
Panahi, Y., Karbasi, A., Valizadegan, G., Ostadzadeh, N., Soflaei, S. S., Jamialahmadi, T., Majeed, M., & Sahebkar, A.
Venue
Advances in Experimental Medicine and Biology
Publisher
Springer International Publishing
Published
2021
Pages
119-126
ISSN
  • 0065-2598
  • 2214-8019
DOI
10.1007/978-3-030-64872-5_10
Cited by
14
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.